Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-02 Sale |
2024-01-03 5:00 pm |
Notable Labs Ltd. | NTBL | FR Capital Holdings L.P. Former 10% Owner |
50,000 | $1.8934 | $94,670 | 880,489 (Indirect) |
View |
| 2023-12-28 Sale |
2024-01-02 5:00 pm |
Notable Labs Ltd. | NTBL | FR Capital Holdings L.P. 10% Owner |
27,500 | $1.9686 | $54,136 | 930,489 (Indirect) |
View |
| 2023-12-26 Sale |
2023-12-28 5:00 pm |
Notable Labs Ltd. | NTBL | FR Capital Holdings L.P. 10% Owner |
31,489 | $2.1106 | $66,460 | 957,989 (Indirect) |
View |
| 2023-12-21 Sale |
2023-12-26 5:00 pm |
Notable Labs Ltd. | NTBL | FR Capital Holdings L.P. 10% Owner |
47,867 | $2.4124 | $115,475 | 989,478 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-09-26 11:07 am |
N/A N/A |
Notable Labs Ltd. | NTBL | Zagger Kaile A. CRO and Interim CEO |
0 | $0 | 0 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 5:18 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | Patsi Tuomo Director |
65,247 | $0 | 65,247 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 5:17 pm |
N/A 2034-05-08 |
Notable Labs Ltd. | NTBL | Wagner Joseph P Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 5:12 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | Galen Michele Director |
40,247 | $0 | 40,247 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 5:09 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | DUBIN THOMAS I H Director |
40,247 | $0 | 40,247 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 5:07 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | Graney Thomas Director |
40,247 | $0 | 40,247 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 5:06 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | Feinberg Peter Director |
40,247 | $0 | 40,247 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 5:04 pm |
N/A 2034-05-08 |
Notable Labs Ltd. | NTBL | Bock Thomas Chief Executive Officer |
550,000 | $0 | 550,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 11:05 am |
N/A 2034-01-24 |
Notable Labs Ltd. | NTBL | Feinberg Peter Director |
9,753 | $0 | 9,753 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 11:05 am |
N/A 2034-01-24 |
Notable Labs Ltd. | NTBL | Patsi Tuomo Director |
9,753 | $0 | 9,753 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 11:04 am |
N/A 2034-01-24 |
Notable Labs Ltd. | NTBL | Galen Michele Director |
9,753 | $0 | 9,753 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 11:04 am |
N/A 2034-01-24 |
Notable Labs Ltd. | NTBL | Graney Thomas Director |
9,753 | $0 | 9,753 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 11:02 am |
N/A 2034-01-24 |
Notable Labs Ltd. | NTBL | DUBIN THOMAS I H Director |
9,753 | $0 | 9,753 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 11:02 am |
N/A 2034-01-24 |
Notable Labs Ltd. | NTBL | RICE YEHUDA MICHAEL Director |
6,534 | $0 | 6,534 (Direct) |
View |
Ownership |
2023-10-26 5:15 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | FR Capital Holdings L.P. 10% Owner |
0 | $0 | 1,037,345 (Indirect) |
View |
Ownership |
2023-10-26 4:15 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | B Capital Fund II L.P. B CAPITAL GROUP PARTNERS II L.P. B CAPITAL GROUP INVESTORS II LTD. B CAPITAL GROUP MANAGEMENT L.P. 10% Owner |
0 | $0 | 1,002,254 (Direct) |
View |
Ownership |
2023-10-19 1:31 pm |
N/A N/A |
Notable Labs Ltd. | NTBL | KIM JAMES JIMIN Builders VC Entrepreneurs Fund I L.P. Builders VC Fund I (Canada) L.P. Builders VC Fund I L.P. 10% Owner |
0 | $0 | 2,319,874 (Indirect) |
View |
Ownership |
2023-10-18 08:40 am |
N/A N/A |
Notable Labs Ltd. | NTBL | DUBIN THOMAS I H Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-10-18 08:37 am |
N/A N/A |
Notable Labs Ltd. | NTBL | Bock Thomas Chief Executive Officer |
0 | $0 | 107,891 (Direct) |
View |
Ownership |
2023-10-18 08:36 am |
N/A N/A |
Notable Labs Ltd. | NTBL | Patsi Tuomo Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-10-18 08:36 am |
N/A N/A |
Notable Labs Ltd. | NTBL | Wagner Joseph P Chief Scientific Officer |
0 | $0 | 23,319 (Direct) |
View |
Ownership |
2023-10-18 08:36 am |
N/A N/A |
Notable Labs Ltd. | NTBL | Galen Michele Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-10-18 08:35 am |
N/A N/A |
Notable Labs Ltd. | NTBL | Feinberg Peter Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-10-18 08:35 am |
N/A N/A |
Notable Labs Ltd. | NTBL | McPherson Scott Alan Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-10-18 08:27 am |
N/A N/A |
Notable Labs Ltd. | NTBL | Graney Thomas Director |
0 | $0 | 0 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-18 4:36 pm |
N/A N/A |
Vascular Biogenics Ltd. | VBLT | Backenroth Samuel Chief Financial Officer |
525,000 | $0 | 700,000 (Direct) |
View |
Ownership |
2023-01-03 9:21 pm |
N/A N/A |
Vascular Biogenics Ltd. | VBLT | KOZIN MARC D Director |
0 | $0 | 471,343 (Indirect) |
View |
Ownership |
2023-01-03 9:06 pm |
N/A N/A |
Vascular Biogenics Ltd. | VBLT | Harats Dror Chief Executive Officer |
0 | $0 | 3,665,475 (Direct) |
View |
Ownership |
2023-01-03 9:05 pm |
N/A 2037-03-21 |
Vascular Biogenics Ltd. | VBLT | Alon Ruth Director |
0 | $0 | 221,113 (Direct) |
View |
Ownership |
2023-01-03 9:04 pm |
N/A 2038-01-02 |
Vascular Biogenics Ltd. | VBLT | HASTINGS DAVID C Director |
0 | $0 | 224,113 (Direct) |
View |
Ownership |
2023-01-03 9:04 pm |
N/A N/A |
Vascular Biogenics Ltd. | VBLT | Backenroth Samuel Chief Financial Officer |
0 | $0 | 1,139,843 (Direct) |
View |
Ownership |
2023-01-03 9:03 pm |
N/A 2041-10-19 |
Vascular Biogenics Ltd. | VBLT | RICE YEHUDA MICHAEL Director |
0 | $0 | 146,113 (Direct) |
View |
Ownership |
2023-01-03 9:03 pm |
N/A N/A |
Vascular Biogenics Ltd. | VBLT | Ben Zvi Shmuel Director |
0 | $0 | 254,113 (Direct) |
View |